CMS Updates Medicare Coverage For LVADs, Artificial Hearts
Agency to eliminate “coverage with evidence development” status
Executive Summary
Patient selection criteria will be the key to allowing CMS coverage of left ventricular assist devices (LVADs) when there is no longer a coverage with evidence development requirement, the US agency wrote.